123 related articles for article (PubMed ID: 476268)
1. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
Sizemore GW; Hpeath H; Larson JM
J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
4. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
[TBL] [Abstract][Full Text] [Related]
5. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
Myhre L; Gautvik KM
Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
8. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin in breast and lung cancer.
Hillyard CJ; Coombes RC; Greenberg PB; Galante LS; MacIntyre I
Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890
[TBL] [Abstract][Full Text] [Related]
10. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma and calcitonin.
Emmertsen K
Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
[TBL] [Abstract][Full Text] [Related]
14. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
[TBL] [Abstract][Full Text] [Related]
16. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
Calmettes C; Moukhtar MS; Milhaud G
Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
[TBL] [Abstract][Full Text] [Related]
17. On the presence of autoantibodies in the plasma of patients suffering from medullary carcinoma of the thyroid.
Calmettes C
Biomed Pharmacother; 1985; 39(4):195-8. PubMed ID: 3904856
[TBL] [Abstract][Full Text] [Related]
18. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
19. Medullary carcinoma of the thyroid gland in Norway. Serum calcitonin in 300 relatives of 43 patients.
Normann T; Gautvik KM
Ann Chir Gynaecol; 1977; 66(4):187-94. PubMed ID: 907311
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
Surg Forum; 1979; 30():120-1. PubMed ID: 395674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
